Evidence map›Paper›PMID 40111516›Full record

ArticleEuropean journal of pediatrics2025

Time to remission in childhood steroid sensitive nephrotic syndrome: a change in perspective.

Beatrice Nardini, Claudio La Scola, Ciro Corrado, Alberto Edefonti, Mario Giordano, Roberto Pillon, Antonio P Mastrangelo, Marco Materassi, Irene Alberici, William Morello and 3 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01386957 (Steroid Treatment of Childhood Idiopathic Nephrotic Syndrome), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01386957 completednot on this map

Steroid Treatment of Childhood Idiopathic Nephrotic Syndrome: Epidemiology, Therapeutic Adequacy, Medium and Long Term Outcomes. A Prospective Observational Cohort Study.

TypeobservationalSponsorIRCCS Azienda Ospedaliero-Universitaria di BolognaRan2011 to 2017Enrolled143ConditionsNephrotic Syndrome
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Beatrice NardiniSpecialty School of Pediatrics, Alma Mater Studiorum, University of Bologna, Bologna, Italy. beatrice.nardini@studio.unibo.it.ORCID http://orcid.org/0009-0009-8490-6857
Claudio La ScolaPediatric Nephrology and Dialysis Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
Ciro CorradoPediatric Nephrology Unit, Children's Hospital "G. Di Cristina", A.R.N.A.S. "Civico", Palermo, Italy.
Alberto EdefontiPediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Mario GiordanoNephrology Unit, XXIII Children's Hospital, Bari, Giovanni, Italy.
Roberto PillonPediatric Nephrology and Dialysis Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
Antonio P MastrangeloPediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Marco Materassi, Florence, Italy.
Irene AlbericiPediatric Nephrology and Dialysis Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
William MorelloPediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Giuseppe Puccio, Palermo, Italy.
Giovanni MontiniPediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Andrea PasiniPediatric Nephrology and Dialysis Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.ORCID http://orcid.org/0000-0001-8479-8379

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Time to remission (TTR) has been largely considered one of the predictive factors for the risk of relapse and steroid dependency in childhood steroid-sensitive nephrotic syndrome, yet conflicting opinions exist. However, the factors influencing TTR have never been studied. We performed a post-hoc analysis of the prospective pediatric cohort enrolled in a previous multicenter study (ClinicalTrials.gov Id: NCT01386957) to evaluate the possible influence of some clinical and laboratory parameters at INS onset on the timing of TTR. A total of 136 children were evaluated. In simple linear regression models, TTR was directly correlated with serum uric acid, urea, potassium, and urinary protein levels at onset. TTR showed a non-linear inverse correlation with age at onset. A multiple linear regression model of TTR showed that hyperuricemia (p = 0.0000007), non linear age (p = 0.0006) and proteinuria (especially in binary form) (p = 0.02) were significant predictors of TTR, and that there was a significant positive interaction between uricemia and proteinuria as predictors of TTR (p = 0.004). Conclusions: In our analysis, TTR appears to be associated to a nephrotic status at clinical diagnosis characterized by more severe proteinuria and hyperuricemia. Moreover, younger age at onset, notably associated with prognosis, is also associated with a longer TTR. What is Known: • Corticosteroids are the first-line treatment in childhood nephrotic syndrome. • Over the years, time to remission has been considered a potential predictive factor for the risk of relapse and steroid dependency in childhood nephrotic syndrome, with conflicting results. What is New: • Clinical and laboratory parameters at nephrotic syndrome onset are associated with prolonged time to remission in children.

Indexed as

GlucocorticoidsNephrotic SyndromeAdolescentAge of OnsetChildChild, PreschoolFemaleHumansHyperuricemiaInfantMalePrognosisProspective StudiesProteinuriaRecurrenceRemission InductionGlucocorticoidsChildhood nephrotic syndromeHypovolemiaSteroid therapyTime to remission

Identifiers

PMID40111516
PMCPMC11926028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.